The Global Breast Imaging Market is expected to grow at a CAGR of 7.4% during the forecasting period (2020-2027).
Breast imaging is used to obtain high-resolution visualization of breast tissues and associated diseases. Breast cancer is the leading cause of the breast disease that requires immediate screening, which in turn is expected to boost the growth of the breast imaging market.
Breast cancer can occur both in men and women, though it is majorly reported in females. The most common breast imaging tests used to determine breast cancer and related disease are ultrasound, mammography, nuclear imaging MRI, and thermography.
Furthermore, mammography is the most preferred imaging techniques for breast cancer diagnosis for the women of age 40 and above.
The growing incidences of breast cancer primarily drive the global market for the global breast imaging market. For instance, according to the American Institute Of Cancer Research (AICR), breast cancer is the most commonly occurring cancer in women and the second most common cancer overall.
There were over 2 million new cases in 2018. Other factors propelling the breast imaging market are the increasing public-private investments, funds, and grants, owing it to increasing awareness on early detection of breast cancer and the aging population. Opportunities in emerging economies offer high growth potential as well as technological advancements in the field.
However, the high cost of breast imaging systems, unfavorable reimbursement scenario, side-effects of radiation exposure may hinder the market growth of breast imaging.
By technology, the breast imaging market is segmented into ionizing breast imaging, non-ionizing breast imaging. The non-ionizing breast imaging segment is expected to show the highest CAGR during the forecast period.
It can be attributed to the advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as high sensitivity to minor breast lesions in dense breast tissues, greater generation of anatomical details for diagnosis, and fewer false positives.
Non-ionized is sub-segmented into MRI, thermography, ultrasound, optical imaging, and automated whole-breast ultrasound.
The ultrasound segment accounted for the largest share of the non-ionizing breast imaging technologies share. It can be attributed to the lower risk of radiation exposure and the advantages offered by breast ultrasound such as the ability to detect lesions and its nature in dense breast tissues, and the capability to differentiate a cyst from a solid mass.
Ionizing is sub-segmented into analog mammography, positron emission mammography, full-field digital mammography, cone-beam computed tomography, electric impedance tomography, positron emission tomography & computed tomography, 3D breast tomosynthesis, and MBI/BSGI.
The mammography segment is the largest share of the ionizing breast imaging technologies market owing to technological advancements in this segment and increasing awareness.
North America dominates the global breast imaging market, owing to it being a crucial contributor to the market as it is technologically advanced and developed region. It has a broad base of the patient population and the presence of significant medical companies.
Moreover, the extensive research activities are undertaken by a majority of prominent players in the area, and the early adoption of advanced medical technologies help the regional market. Other factors are the high spending of GDP in healthcare, especially in the US and Canada, and increasing initiatives by the government.
Europe is expected to show significant growth in the breast imaging market, owing to the increasing prevalence of breast cancer among women in this region. According to the United Nations Children’s Fund (UNICEF), annually in England, approximately 41,000 new cases of women are diagnosed.
The Asia Pacific is expected to witness a significant growth owing it to the increasing awareness among individuals in the region.
The region’s large population base also contributes to the high growth market. According to the International Association of Cancer Registries, breast cancer cases reported in Asia accounts for 39% of all breast cancers diagnosed worldwide.
Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New and innovative product launches is another strategy adopted by the leading players to improve their market presence.
March 2018, Royal Philips, a global leader in health technology, and Hologic, an innovative women’s health company, announced a global partnership agreement to offer care professionals integrated solutions comprising diagnostic imaging modalities, advanced informatics, and services for screening, diagnosis and treatment of women across the world.
The collaboration combines Hologic’s innovative mammography technologies and Philips’ leading portfolio of MRI, CT, X-ray, and ultrasound systems, advanced informatics and the broad range of services.
March 2018, Hologic, received PMA approval from FDA for its innovations on the Clarity HD high-resolution 3D imaging and intelligent 2D imaging technology and are available on the 3Dimensions breast tomosynthesis system.
In 2017, CMR Naviscan Corporation acquired some assets of Gamma Medica Molecular Breast Imaging Technology, aiming to expand its Breast PET Imaging Solutions.
In 2017, Canon, Inc. established the Yokohama Development Center in Tsurumi Ward, Yokohama, aiming to expand its operations and pioneer new business opportunities.
In April 2016, Fujifilm India Pvt Ltd collaborated with NM Medical, for the installation of Fujifilm’s 50 Micron 3D Mammography machine-a highly advanced breast cancer diagnostic machine used to detect breast cancer among women at an early stage.
• Visualize the composition of the global Breast Imaging Market across each indication, in terms of type and treatment options, highlighting the key commercial assets and players.
• Identify commercial opportunities in global Breast Imaging Market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of the global Breast Imaging Market – level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key products of all major market players
• Equipment Suppliers/ Buyers
• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
1.1. Research Methodology
1.2. Scope of the market
2.1. Key Trends and Developments
3.3. Supply Chain Analysis
3.5. Key Developments
4.1. By Technology
22.214.171.124. Full-Field Digital Mammography
126.96.36.199. Analog Mammography
188.8.131.52. Positron Emission Mammography
184.108.40.206. Electric Impedance Tomography
220.127.116.11. Cone-Beam Computed Tomography
18.104.22.168. Positron Emission Tomography & Computed Tomography
22.214.171.124. 3D Breast Tomosynthesis
126.96.36.199. Optical Imaging
188.8.131.52. Automated Whole-Breast Ultrasound
5.1. Geographic Overview
5.2. North America
5.3.4. Rest of Europe
5.4. South America
5.4.3. Rest of South America
5.5. Asia Pacific
5.5.5. Rest of Asia Pacific
5.6. Rest of World
6.1. Competitive Scenario
6.2. Key Strategies adopted by Manufacturers
6.3. Product Benchmarking
7.1. GE Healthcare
7.2. Siemens Healthcare
7.3. Philips Healthcare
7.4. Hitachi Medical Corporation
7.5. Fujifilm Holdings Corporation
7.6. Hologic, Inc.
7.7. Canon Medical Systems USA Inc.
7.8. Toshiba Corporation
7.9. Aurora Imaging Technology, Inc.
7.10. Gamma Medica
8.2. List of Tables
8.3. Expert Panel Validation
8.5. Contact Us
Get your FREE SAMPLE PROPOSAL with a single click!